KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares OutstandingShares OutstandingShares RepurchasedShort-Term Debt issuances
Ratios

Thermo Fisher Scientific (TMO) Long-Term Debt Repayments (2016 - 2026)

Thermo Fisher Scientific filings provide 16 years of Long-Term Debt Repayments readings, the most recent being $1.4 billion for Q1 2026.

  • On a quarterly basis, Long-Term Debt Repayments rose 68.5% to $1.4 billion in Q1 2026 year-over-year; TTM through Mar 2026 was $3.0 billion, a 32.82% decrease, with the full-year FY2025 number at $2.4 billion, down 33.13% from a year prior.
  • Long-Term Debt Repayments hit $1.4 billion in Q1 2026 for Thermo Fisher Scientific, up from $787.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $3.8 billion in Q4 2023 to a low of $375.0 million in Q2 2022.
  • Median Long-Term Debt Repayments over the past 5 years was $1.0 billion (2023), compared with a mean of $1.4 billion.
  • Biggest five-year swings in Long-Term Debt Repayments: plummeted 86.62% in 2022 and later soared 68.5% in 2026.
  • Thermo Fisher Scientific's Long-Term Debt Repayments stood at $375.0 million in 2022, then surged by 908.53% to $3.8 billion in 2023, then crashed by 33.9% to $2.5 billion in 2024, then crashed by 68.52% to $787.0 million in 2025, then soared by 79.42% to $1.4 billion in 2026.
  • The last three reported values for Long-Term Debt Repayments were $1.4 billion (Q1 2026), $787.0 million (Q4 2025), and $787.0 million (Q2 2025) per Business Quant data.